2-[1-(4-nitrophenyl)-4-piperidyl]ethanol | 165606-80-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: 2-[1-(4-nitrophenyl)-4-piperidyl]ethanol
• 英文别名: 2-[1-(4-nitrophenyl)piperidin-4-yl]ethanol；2-[1-(4-Nitrophenyl)piperidin-4-yl]ethan-1-ol
• CAS: 165606-80-4
• 化学式: C₁₃H₁₈N₂O₃
• 分子量: 250.298
• InChiKey: MNRDSPBDDKOWKJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  18
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.54
• 拓扑面积：
  69.3
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  2-[1-(4-nitrophenyl)-4-piperidyl]ethanol 、 甲基磺酰氯 在 三乙胺 作用下， 以 四氢呋喃 为溶剂， 生成
  参考文献：
  名称：

  DIAMINOPYRIMIDINECARBOXA MIDE DERIVATIVE

  摘要：

  公开号：

  EP1518855B1
• 作为产物：
  描述：

  4-哌啶乙醇 、 对氟硝基苯 在 N,N-二异丙基乙胺 作用下， 以 二甲基亚砜 为溶剂， 以9.1 g的产率得到2-[1-(4-nitrophenyl)-4-piperidyl]ethanol
  参考文献：
  名称：

  [EN] COMPOUND CONTAINING HETEROCYCLIC RING
  [FR] COMPOSÉ CONTENANT UN ANNEAU HÉTÉROCYCLIQUE
  [ZH] 含有杂环的化合物

  摘要：

  本申请涉及含有杂环的化合物，具体而言涉及式I'化合物或其药学上可接受的盐、其制备方法、含有该化合物的药物组合物、以及其在治疗相关疾病(例如癌症)中的用途。

  公开号：

  WO2023125944A1

文献信息

• PIPERAZINE COMPOUND CAPABLE OF INHIBITING PROSTAGLANDIN D SYNTHASE
  申请人：Urade Yoshihiro

  公开号：US20110319413A1

  公开（公告）日：2011-12-29

  This invention relates to a piperazine compound represented by Formula (I), wherein R 1 is C 1-6 alkyl; R 2 is hydroxy, C 1-6 alkyl that may have one or more substituents, —(C═O)—N(R 3 )(R 4 ), or —(C═O)—OR 5 ; R 3 and R 4 are the same or different, and each represents hydrogen or C 1-6 alkyl that may have one or more substituents, or R 3 and R 4 , taken together with a nitrogen atom to which R 3 and R 4 are attached, may form a saturated heterocyclic group; R 5 is hydrogen or C 1-6 alkyl that may have one or more substituents; and n is 1 or 2; or a salt thereof.

  该发明涉及一种由式（I）表示的哌嗪化合物，其中R1是C1-6烷基；R2是羟基，可能具有一个或多个取代基的C1-6烷基，—(C═O)—N(R3)(R4)，或—(C═O)—OR5；R3和R4相同或不同，每个代表氢或可能具有一个或多个取代基的C1-6烷基，或R3和R4与R3和R4连接的氮原子一起，可能形成饱和杂环基团；R5是氢或可能具有一个或多个取代基的C1-6烷基；n为1或2；或其盐。
• Diaminopyrimidinecarboxa mide derivative
  申请人：Nagashima Shinya

  公开号：US20050272753A1

  公开（公告）日：2005-12-08

  A compound which may be used for the prevention or treatment of respiratory diseases in which STAT 6 is concerned, particularly asthma, chronic obstructive pulmonary disease and the like is provided. A pyrimidine derivative or a salt thereof, which has an arylamino or arylethylamino group which may be substituted with a specified substituent, at the 2-position, amino group substituted with benzyl group or the like, at the 4-position, and carbamoyl group which may be substituted, at the 5-position, is provided.

  提供了一种可用于预防或治疗呼吸道疾病，特别是哮喘、慢性阻塞性肺病等与STAT 6有关的化合物。该化合物是一种嘧啶衍生物或其盐，其在2位具有可以被指定取代基取代的芳基氨基或芳基乙基氨基，4位具有被苄基基团或类似基团取代的氨基，5位具有可以被取代的氨基甲酰基。
• Diaminopyrimidinecarboxamide Derivative
  申请人：Nagashima Shinya

  公开号：US20090281072A1

  公开（公告）日：2009-11-12

  A compound which may be used for the prevention or treatment of respiratory diseases in which STAT 6 is concerned, particularly asthma, chronic obstructive pulmonary disease and the like is provided. A pyrimidine derivative or a salt thereof, which has an arylamino or arylethylamino group which may be substituted with a specified substituent, at the 2-position, amino group substituted with benzyl group or the like, at the 4-position, and carbamoyl group which may be substituted, at the 5-position, is provided.

  提供了一种可用于预防或治疗呼吸系统疾病，特别是哮喘、慢性阻塞性肺疾病等与STAT 6有关的化合物。该化合物为嘧啶衍生物或其盐，其在2位具有可被取代的芳基氨基或芳基乙基氨基基团，4位具有氨基取代的苯甲基基团或类似基团，5位具有可被取代的氨基甲酰基团。
• DIAMINOPYRIMIDINECARBOXAMIDE DERIVATIVE
  申请人：Nagashima Shinya

  公开号：US20110294749A1

  公开（公告）日：2011-12-01

  A compound which may be used for the prevention or treatment of respiratory diseases in which STAT 6 is concerned, particularly asthma, chronic obstructive pulmonary disease and the like is provided. A pyrimidine derivative or a salt thereof, which has an arylamino or arylethylamino group which may be substituted with a specified substituent, at the 2-position, amino group substituted with benzyl group or the like, at the 4-position, and carbamoyl group which may be substituted, at the 5-position, is provided.

  提供了一种可用于预防或治疗涉及STAT 6的呼吸系统疾病，特别是哮喘、慢性阻塞性肺疾病等的化合物。该化合物为嘧啶衍生物或其盐，其在2位具有可以被指定取代基取代的芳基氨基或芳基乙基氨基基团，在4位具有可以被苄基或类似物取代的氨基基团，并在5位具有可以被取代的氨基甲酰基团。
• Diaminopyrimidinecarboxamide derivative
  申请人：Astellas Pharma, Inc.

  公开号：US07449456B2

  公开（公告）日：2008-11-11

  A compound which may be used for the prevention or treatment of respiratory diseases in which STAT 6 is concerned, particularly asthma, chronic obstructive pulmonary disease and the like is provided. A pyrimidine derivative or a salt thereof, which has an arylamino or arylethylamino group which may be substituted with a specified substituent, at the 2-position, amino group substituted with benzyl group or the like, at the 4-position, and carbamoyl group which may be substituted, at the 5-position, is provided.

  提供一种化合物，可用于预防或治疗涉及STAT 6的呼吸系统疾病，特别是哮喘、慢性阻塞性肺疾病等。该化合物是一种嘧啶衍生物或其盐，其在2位具有可以被指定取代基取代的芳基氨基或芳基乙基氨基，4位上具有被苯甲基等基团取代的氨基，5位上具有可以被取代的氨基甲酰基。